Evidence map›Paper›PMID 25671541›Full record

ArticlePloS one2015

High-affinity accumulation of a maytansinoid in cells via weak tubulin interaction.

Victor S Goldmacher, Charlene A Audette, Yinghua Guan, Eriene-Heidi Sidhom, Jagesh V Shah, Kathleen R Whiteman, Yelena V Kovtun

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Victor S GoldmacherDepartment of Cell Biology, ImmunoGen, Inc., Waltham, Massachusetts, United States of America.
Charlene A AudetteDepartment of Cell Biology, ImmunoGen, Inc., Waltham, Massachusetts, United States of America.
Yinghua GuanDepartment of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America; Renal Division, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Eriene-Heidi SidhomDepartment of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America; Renal Division, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Jagesh V ShahDepartment of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America; Renal Division, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Kathleen R WhitemanDepartment of Cell Biology, ImmunoGen, Inc., Waltham, Massachusetts, United States of America.
Yelena V KovtunDepartment of Cell Biology, ImmunoGen, Inc., Waltham, Massachusetts, United States of America.
ImmunoGen (United States) · USBrigham and Women's Hospital · USHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The microtubule-targeting maytansinoids accumulate in cells and induce mitotic arrest at 250- to 1000-fold lower concentrations than those required for their association with tubulin or microtubules. To identify the mechanisms of this intracellular accumulation and exceptional cytotoxicity of maytansinoids we studied interaction of a highly cytotoxic maytansinoid, S-methyl DM1 and several other maytansinoids with cells. S-methyl DM1 accumulated inside the cells with a markedly higher apparent affinity than to tubulin or microtubules. The apparent affinities of maytansinoids correlated with their cytotoxicities. The number of intracellular binding sites for S-methyl DM1 in MCF7 cells was comparable to the number of tubulin molecules per cell (~ 4-6 × 10(7) copies). Efflux of 3[H]-S-methyl DM1 from cells was enhanced in the presence of an excess of non-labeled S-methyl DM1, indicating that re-binding of 3 [H]-S-methyl DM1 to intracellular binding sites contributed to its intracellular retention. Liposomes loaded with non-polymerized tubulin recapitulated the apparent high-affinity association of S-methyl DM1 to cells. We propose a model for the intracellular accumulation of maytansinoids in which molecules of the compounds diffuse into a cell and associate with tubulin. Affinities of maytansinoids for individual tubulin molecules are weak, but the high intracellular concentration of tubulin favors, after dissociation of a compound-tubulin complex, their re-binding to a tubulin molecule, or to a tip of a microtubule in the same cell, over their efflux. As a result, a significant fraction of microtubule tips is occupied with a maytansinoid when added to cells at sub-nanomolar concentrations, inducing mitotic arrest and cell death.

Indexed as

Cell Line, TumorDose-Response Relationship, DrugHumansLiposomesMaytansineMicrotubulesModels, BiologicalProtein BindingTubulinLiposomesMaytansineTubulin

Identifiers

PMID25671541
PMCPMC4324968
OpenAlexW2120350077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.